SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-21-000014
Filing Date
2021-01-04
Accepted
2021-01-04 11:05:37
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 144549
2 filename2.txt TEXT-EXTRACT 7120
  Complete submission text file 0000000000-21-000014.txt   206967
Mailing Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016 917-336-9310
Prevail Therapeutics Inc. (Filed for) CIK: 0001714798 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)